Bio-Rad Laboratories, a global leader in life science research and clinical diagnostics, has expanded its Pioneer™ Antibody Discovery Platform services by introducing the fast generation and screening of bispecific antibodies through its proprietary SpyLock Technology. This new service enables rapid development and screening, helping customers identify effective antibody combinations for further development. The Pioneer Platform, which includes a fully human synthetic phage display library of 225 billion unique Fab antibodies and the SpyDisplay technology, offers high-quality antibody candidates and customizable discovery services.
The platform is widely used across applications such as immuno-oncology and infectious diseases. A notable partnership with Salipro Biotech has already yielded novel human antibodies with superior affinities against challenging GPCR targets. Bio-Rad’s enhanced services, including the addition of SpyLock, underscore its commitment to providing researchers with cutting-edge tools to screen bispecific antibody candidates efficiently.
This article is a summary of a published press release
